The Harley Street Journal

Bi-monthly newspaper for the cosmetic and plastic surgery sector

laser technology

Treatment In Focus: RevLite laser from Cynosure

by

10177840_xxlCynosure’s new FDA-cleared RevLite laser is the latest market-leader for skin lightening and treating difficult skin conditions including acne and acne scarring, fine lines and wrinkles, hyperpigmentation and melasma. RevLite offers faster treatment times and 60% more power than its laser predecessors, with minimal downtime for all skin types.

Innovative PhotoAcoustic Technology Pulse results in less trauma to skin’s surface. Proprietary PhotoAcoustic action forces energy at such a high rate that molecules in the skin vibrate and shatter. This PhotoAcoustic action is worlds apart from the more traditional photothermal effect that ordinary laser systems use; resulting in minimal damage to the skin’s epidermal layer.

How does RevLite work?

The revolutionary Q-switched technology uses a pulsed beam of light and optimum power to shatter dark skin particles, which are gradually removed by the body’s natural processes. The machine’s flattop beam distributes the energy evenly over the problematic skin area or dark pigmentation encouraging it to fade and disappear over time. The energy pulsed (one billionth of a second) through the skin is faster than the relaxation time of the healthy tissue, thus minimising redness and recovery time. In fact, the pulse is so fast it provides safe and effective results even if the pigmentation has existed for decades, leaving the skin healthy and rejuvenated.

Award-winning, proven technology treats even stubborn tattoos with virtually no risk of scarring or changes to skin pigment. This versatile laser can also be used to treat birthmarks, sun damage, freckling and brown spots.

Anti-ageing Maintenance with RevLite

RevLite is the safest, fastest and most effective method for skin rejuvenation, either as a one-off treatment or as part of an on-going Anti-ageing Maintenance regime. The machine’s PhotoAcoustic shockwaves reorder the skin’s collagen into a group of collagen fibres, tightening skin and encouraging it to repair and rejuvenate itself, with no downtime.

A recent clinical study of patients treated with RevLite over 6 bi-weekly sessions, demonstrated impressive results in improving the depth and number of wrinkles, appearance of pores, number of whiteheads and skin laxity.

Cynosure’s RevLite is the latest champion in skin rejuvenation and is available at the Angel Laser Clinic. Visit www.angellaserclinic.co.uk for more information.

Cynosure Launch Icon: The First Laser That Grows Skin

by

APSARAS4Cynosure have developed the first laser treatment which can completely erase scarring.

The newly-launched Icon laser can treat all kinds of scarring including stretch marks, acne scarring, burn scars and surgical scars.

The laser is equipped with the only FDA-approved Skintel melanin reader, which analyses your skin type, and transmits this vital information wirelessly. The laser then cleverly sets itself into the optimal conditions for your specific skin type, using A.I. to deliver truly tailored results.

The non-ablative fractionated laser directs microscopic columns of heat deep into the dermis, leaving the surrounding tissue and epidermis intact. This deep heat triggers a restorative healing response in the skin, stimulating collagen production and allowing the skin to renew itself, gently replacing the scarred skin with fresh healthy tissue. The area blends naturally with the surrounding skin, as if it was never there.

Until now, clinicians have had to rely on relatively subjective tools to determine skin type, but the Skintel Melanin Reader can provide an incredibly accurate analysis of the skin.

//BOX OUT//

With the Icon system, aesthetic practices can provide the most popular treatments, including:

  • laser skin resurfacing
  • laser wrinkle reduction
  • laser scar and stretch mark treatment
  • permanent hair reduction
  • vessel and pigment clearance
  • leg vein clearance

Factors such as the pigmentation amount and level of sun exposure will be revealed and automatically programmed by the Icon laser, providing the best possible results.

A spokesperson for Cynosure said:

“It represents a new era in laser and optimised light technology. The Icon Aesthetic System offers high peak powers, state-of-the-art cooling, built in calibration, and the Skintel® Reader, the only FDA-cleared melanin reader, resulting in fast treatments with excellent outcomes.”

More information can be found at www.cynosure.com

Cynosure Completes Acquisition of Palomar Medical Technologies

by

Image-3Cynosure, Inc. (NASDAQ: CYNO), a leader in laser- and light-based treatments for minimally invasive and non-invasive aesthetic applications, today announced the completion of its acquisition of Palomar Medical Technologies, Inc.  Cynosure purchased Palomar in a cash and stock transaction valued at approximately $287 million.  In the transaction, Cynosure issued approximately six million shares and paid approximately $146 million in cash contributed by both Cynosure and Palomar.

“Combining with Palomar brings together two world class research and development organizations creating what we believe is one of the world’s premier aesthetic laser and light-based companies,” said Michael Davin, Cynosure’s Chairman and Chief Executive Officer.

“We believe the acquisition complements our product portfolio and customer base, provides new product and service revenues, strengthens our global distribution network, opens new cross-selling opportunities and enhances our intellectual property position.  We appreciate the overwhelming support of our stockholders in recognizing the value of this transaction to our long-term growth strategy.  We welcome Palomar’s employees to the Cynosure team and look forward to the continued success of our unified organisation.”

The closing of the transaction follows approvals by Cynosure stockholders and Palomar stockholders at separate stockholders’ meetings today.  At the Cynosure stockholders’ meeting, Cynosure stockholders approved the issuance of shares of Cynosure Class A common stock in the merger.  At the Palomar stockholders’ meeting, Palomar stockholders adopted the merger agreement between the companies.  Under the terms of the agreement, each outstanding share of Palomar common stock converted into the right to receive $6.825 in cash and 0.2819 shares of Cynosure Class A common stock.

As previously announced, the acquisition is expected to be accretive to Cynosure in calendar 2014 with the implementation of $8 million to $10 million in projected synergies.   Following the closing, Michael Davin will serve as Chairman and Chief Executive Officer; Joseph Caruso has joined Cynosure’s Board of Directors as Vice Chairman and will serve as President; and Timothy Baker will serve as Executive Vice President, Chief Operating Officer and Chief Financial Officer.


Cynosure develops and markets aesthetic treatment systems that enable plastic surgeons, dermatologists and other medical professionals to perform non-invasive and minimally invasive procedures to remove hair, treat vascular and benign pigmented lesions, remove multi-colored tattoos, rejuvenate the skin, liquefy and remove unwanted fat through laser lipolysis, reduce cellulite, treat toe fungus and ablate sweat glands.  Cynosure’s product portfolio is composed of a broad range of energy sources including Alexandrite, diode, Nd: YAG, picosecond, pulse dye, Q-switched lasers and intense pulsed light.   Cynosure sells its products globally under the Cynosure, Palomar and ConBio brand names through a direct sales force in the United States, Canada, Mexico, France, Germany, Spain, the United Kingdom, Australia, China, Japan and Korea, and through international distributors in approximately 100 other countries.